We are live on ! Find out more

9 hedge funds and large institutions have $1.69M invested in PAVmed in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0.01% more ownership

Funds ownership: 0.01%0.02% (+0.01%)

9% less capital invested

Capital invested by funds: $1.86M → $1.69M (-$174K)

18% less funds holding

Funds holding: 119 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$1.33M +$666K +1,089 +54%
LCS
2
Levin Capital Strategies
New York
$206K +$200K +327 +210%
Vanguard Group
3
Vanguard Group
Pennsylvania
$90K +$45.9K +75 +55%
MSAM
4
Moloney Securities Asset Management
Missouri
$30K -$1.22K -2 -3%
Jane Street
5
Jane Street
New York
$17K +$23.8K +39 New
Morgan Stanley
6
Morgan Stanley
New York
$10K
Fifth Third Bancorp
7
Fifth Third Bancorp
Ohio
$4K
SEI Investments
8
SEI Investments
Pennsylvania
$2K +$1.22K +2 +100%
UBS Group
9
UBS Group
Switzerland
$1K -$11.6K -19 -86%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
-$43K -58 Closed
Brown Advisory
11
Brown Advisory
Maryland
-$16K -22 Closed
BlackRock
12
BlackRock
New York
-$1K -2 Closed

PAVM Hedge Fund Activity: Q2 2018 in Review

9 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2018, worth a combined $1.69M — down 9.3% from $1.86M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PAVM and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Sabby Management, adding an estimated $666K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $43K sold.

  • 9 institutional investors held PAVmed (PAVM) as of Q2 2018, down from 11 in Q1 2018.
  • Funds reported $1.69M of PAVmed stock for Q2 2018, down 9.3% quarter-over-quarter.
  • 1 fund opened new PAVmed positions in Q2 2018 and 3 closed out, a net change of -2 holders.
  • The largest PAVmed buyer in Q2 2018 was Sabby Management, an estimated $666K added.
  • The largest PAVmed seller in Q2 2018 was Susquehanna International Group, an estimated $43K sold.

Based on aggregated 13F filings for Q2 2018.